Strainsforpains Reports $300K CBD Sales, Targets $2M Revenue in 2025 with AI-Powered Expansion
[[{"value":"Rhea-AI Impact(Neutral)Rhea-AI Sentiment(Positive)Rhea-AI SummaryStrainsforpains (OTC: EBYH) reported significant growth in 2024 with over $300,000 in CBD sales and projects reaching $2 million in sales by end of 2025. The company…